Purchase SGT-263/151/25/67/78

With us securely! - re-shipment guarantees.

We always offer new legal products of impeccable quality.

Please make sure that the product is legal in your country and not under control before ordering.

We do not sell pharmaceutical products or controlled products.

Where to buy SGT-263/151/25/67/78 for sale

CUMYL-4CN-BINACA is an indazole-3-carboxamide-based synthetic cannabinoid sold online as a designer drug. It is a potent agonist for cannabinoid receptors CB1 and CB2, with in vitro EC50 values of 0.58 nM and 6.12 nM, respectively. CUMYL-5F-P7AICA is a pyrrolo[2,3-b] pyridine-3-carboxamide-based synthetic cannabinoid sold as a designer drug. The EMCDDA first identified it in February 2015.

CUMYL-4CN-BINACA (also known as CUMYL-CYBINACA or SGT-78) is an indazole-3-carboxamide-based synthetic cannabinoid sold online as a designer drug. It is a potent agonist for cannabinoid receptors CB1 and CB2, with in vitro EC50 values of 0.58 nM and 6.12 nM, respectively.

CUMYL-4CN-BINACA (also known as CUMYL-CYBINACA or SGT-78), 5F-CUMYL-P7AICA (also known as CUMYL-5F-P7AICA or SGT-263), and CUMYL-PEGACLONE (SGT-151) are synthetic cannabinoids. They possess multiple pharmacological effects, including analgesic effects, cardiovascular effects and mood stimulation.

These are synthetic cannabinoids. They possess multiple pharmacological effects, including analgesic effects, cardiovascular effects, and mood stimulation.

5F-CUMYL-P7AICA is a synthetic cannabinoid that has been sold as a designer drug. It was initially sold in China and Japan, though it has since spread to other countries. In the United States, 5F-CUMYL-P7AICA has been linked to at least one death, and several hospitalizations in Arizona (with symptoms of agitation, confusion and seizures) have been linked to an overdose of the drug.

5F-CUMYL-P7AICA is a synthetic cannabinoid that has been sold as a designer drug. It was initially sold in China and Japan, though it has since spread to other countries. 5F-CUMYL-P7AICA has been linked to at least one death in the United States, several hospitalizations with symptoms of agitation and confusion in Arizona, and seizures.

5F-CUMYL-P7AICA is a synthetic cannabinoid closely related to UR-144, XLR-11 and AB-FUBINACA.

5F-CUMYL-P7AICA is a designer drug.

CUMYL-4CN-BINACA (also known as CUMYL-CYBINACA or SGT-78) is an indazole-3-carboxamide-based synthetic cannabinoid sold online as a designer drug. It is a potent agonist for cannabinoid receptors CB1 and CB2, with in vitro EC50 values of 0.58 nM and 6.12 nM, respectively.

CUMYL-4CN-BINACA (also known as CUMYL-CYBINACA or SGT-78) is an indazole-3-carboxamide-based synthetic cannabinoid sold online as a designer drug. It is a potent agonist for cannabinoid receptors CB1 and CB2,

CUMYL-4CN-BINACA and 5F-CUMYL-P7AICA have been identified as cannabinoids of emerging concern. CUMYL-4CN-BINACA was first identified in June 2015 by the EMCDDA and has been sold online as a designer drug.

Commonly used as a research chemical and has been linked to deaths. The compound is also identified with other names, including SGT-263, 5F-CUMYL-P7AICA, CUMYL-5F-P7AICA and respectively as SGT-25, SGT-67, CUMYL-4CN-BINACA(CUMYL-CYBINACA).

CUMYL-4CN-BINACA is an indazole-3-carboxamide-based synthetic cannabinoid sold online as a designer drug. SGT-263/151/25/67/78 are pyrrolo[2,3-b]pyridine-3-carboxamide based synthetic cannabinoids that have been sold as designer drugs

CUMYL-4CN-BINACA (also known as CUMYL-CYBINACA or SGT-78) is an indazole-3-carboxamide-based designer synthetic cannabinoid with potent agonist activity for CB1 and CB2.